A novel mechanism for the regulation of amyloid precursor protein metabolism

Qi Chen1, Hideo Kimura, David Schubert

  • 1Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Insights

Modifier of cell adhesion protein (MOCA) reduces amyloid precursor protein (APP) secretion and cell adhesion by targeting APP for proteasomal degradation. This discovery reveals a novel mechanism regulating APP expression, potentially impacting Alzheimer's disease (AD) pathology.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Modifier of cell adhesion protein (MOCA) interacts with presenilin (PS) proteins, implicated in Alzheimer's disease (AD).
  • MOCA is localized to AD-affected brain regions and reduced in sporadic AD brains.
  • PS1's association with gamma-secretase suggests MOCA's role in beta-amyloid precursor protein (APP) processing.

Purpose of the Study:

  • To investigate the role of MOCA in APP processing and cell adhesion.
  • To elucidate the mechanism by which MOCA affects APP secretion and cellular behavior.

Main Methods:

  • Assessed the impact of MOCA expression on APP and amyloid beta-peptide secretion.
  • Measured cell-substratum adhesion rates.
  • Investigated the effect of MOCA on amyloid precursor-like protein (APLP) secretion.
  • Utilized proteasome inhibitors to explore the degradation pathway of APP.

Main Results:

  • MOCA expression decreased both APP and amyloid beta-peptide secretion.
  • MOCA reduced cell-substratum adhesion rates.
  • MOCA did not affect the secretion of APLP or other type 1 membrane proteins.
  • Phenotypic changes were attributed to accelerated intracellular APP degradation via proteasomes.
  • Proteasome inhibitors reversed MOCA's effects on APP secretion and cell adhesion.

Conclusions:

  • MOCA plays a significant role in APP metabolism.
  • MOCA directs nascent APP to proteasomes for degradation, a novel regulatory mechanism.
  • MOCA's effects on APP secretion and cell adhesion are downstream consequences of APP catabolism.
  • This mechanism offers new insights into APP expression regulation and potential AD therapeutic targets.

Related Concept Videos

Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Biosynthesis of Polysaccharides01:26

Biosynthesis of Polysaccharides

Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...